An overview of the active clinical trials for Parkinson's disease psychosis

Neurodegener Dis Manag. 2022 Aug;12(4):165-170. doi: 10.2217/nmt-2022-0020. Epub 2022 May 20.

Abstract

Tweetable abstract An overview of the active clinical trials for Parkinson's disease psychosis. In this article, we review the drugs currently undergoing clinical testing for Parkinson's disease psychosis and offer some perspectives on the treatment of the condition.

Keywords: AZD0328; DAAOI-P; ENT-01; NYX-458; Parkinson’s disease; SEP-363856; apomorphine; cannabis; carvedilol; nelotanserin; ondansetron; saracatinib.

Publication types

  • Editorial
  • Review

MeSH terms

  • Clinical Trials as Topic
  • Humans
  • Parkinson Disease* / drug therapy
  • Psychotic Disorders* / drug therapy